Ross P D, Davis J W, Wasnich R D
Hawaii Osteoporosis Center, Honolulu 96814.
Calcif Tissue Int. 1993;53 Suppl 1:S134-7; discussion S137-8. doi: 10.1007/BF01673422.
Numerous prospective studies have demonstrated a strong relationship between bone mass and fracture risk. The fact that the bone mass distributions of fracture and nonfracture cases overlap does not necessarily indicate a shortcoming of bone mass, but might instead be due to the sporadic nature of falls and the influence of other fracture risk factors. The recent finding that prevalent fractures are strong predictors of fracture risk, independent of bone mass, suggests (but does not prove) that there may be other, potentially measurable fracture risk factors that complement, and act independently of, bone mass. This paper reviews possible mechanisms by which prevalent fractures might serve as etiologic risk factors, or as surrogate indicators of other risk factors. Potential risk factors other than bone mass and prevalent fractures are also considered. Whether or not etiologic fracture risk factors other than bone mass can be identified, it appears that treatments that influence bone will be most effective if begun early, before bone strength becomes impaired and fractures begin to occur.
众多前瞻性研究已证实骨量与骨折风险之间存在密切关系。骨折病例和未骨折病例的骨量分布存在重叠这一事实,并不一定表明骨量存在缺陷,而可能是由于跌倒的随机性以及其他骨折风险因素的影响。最近的研究发现,既往骨折是骨折风险的有力预测指标,独立于骨量之外,这表明(但未证明)可能存在其他潜在可测量的骨折风险因素,它们与骨量相互补充且独立起作用。本文回顾了既往骨折可能作为病因性风险因素或其他风险因素替代指标的可能机制。还考虑了除骨量和既往骨折之外的潜在风险因素。无论能否识别出除骨量之外的病因性骨折风险因素,似乎在骨强度受损和骨折开始发生之前尽早开始影响骨骼的治疗将最为有效。